Safety of rotigotine patch for ADPKD patients
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a skin patch called rotigotine to see if it is safe for people with ADPKD. It may help with blood pressure control, but you cannot have advanced kidney failure or certain other health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old and have ADPKD (autosomal dominant polycystic kidney disease).
- Your blood pressure must be well controlled (below 135/85 mmHg on average during the day).
- You cannot have advanced kidney failure (stage 4 or 5) or be on dialysis or have a kidney transplant.
- You cannot have had a heart attack or stroke in the past 6 months, or have severe liver disease.
- You must not have taken certain medications called dopamine agonists or antagonists in the last 6 months.
- You cannot have a history of addiction (gambling, alcohol over 20g/day, drug use) or be pregnant/breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether radotinib is safe and tolerable, and whether it can help people with early Parkinson’s disease. It also checks how the body absorbs and processes the drug.
This trial tests whether a new rotigotine skin patch (Rotigexole) works as well and is as safe as the existing patch (Neupro). It is for people with Parkinson's who are in moderate stages and have not used similar dopamine agonist drugs recently.
This trial tests if adding a rotigotine patch to your usual rivastigmine treatment can help with symptoms of Alzheimer's. It is for people with mild to moderate Alzheimer's who have been stable on rivastigmine for at least 3 months.
This study tests a new investigational drug called GV-100 to see how safe it is and how the body handles it. It is for healthy adults and will be given in different doses to find the best one.
This Phase 2 study tests whether a rotigotine skin patch, used alongside behavioral therapy, can help people reduce cocaine use. It also looks at changes in brain activity while you do study tasks.
This trial tests a new study drug called AZD1613 for adults with a certain type of kidney disease (ADPKD). Researchers want to see if it is safe, how the body handles it, and what the right dose might be.
Hear when a new Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.